Loading patent…
OwnerFloyd Chilton, Marc Surette +2inventors
InventorsFloyd Chilton, Marc Surette, Iphigenia Koumenis, Kenneth Tramposch
Estimating the term…
Compositions, dietary supplements and medical foods for the treatment of symptoms of inflammatory disorders may include gamma-linolenic acid or dihomogammalinolenic acid, an inhibitor of Δ5 desaturase, and optionally stearidonic acid or ω−3 arachidonic acid. Preferred formulations may be in the form of a good tasting, preferably milk or fruit based drink, or a dried powder. Compositions reduce inflammation and inhibit increase in serum arachidonic acid associated with gamma-linolenic acid. The compositions of the invention may also be used for the treatment of cytokine mediated disorders in patients in need thereof.
A composition consisting essentially of a leukotriene inhibitor in an amount from about 0.2 grams to about 3 grams, and a Δ5 desaturase inhibitor in an amount effective to prevent an increase in arachidonic acid metabolites, said composition optionally comprising an inhibitor of arachidonic acid metabolism.
(canceled)
(canceled)
An emulsion consisting essentially of a leukotriene inhibitor in an amount from about 0.2 grams to about 3 grams, a Δ5 desaturase inhibitor in an amount effective to prevent an increase in arachidonic acid metabolites, at least one emulsifying agent or emulsion stabilizer, and water, said emulsion optionally further 1-5 comprising an inhibitor of arachidonic acid metabolism.
(canceled)
-25. (canceled)
-93. (canceled)
Dependencies are inferred from the claim text.